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During the first ‘wave’ of the COVID-19 pandemic there was concern that health systems 
could be overwhelmed. The surges of COVID-19 infections and hospital admissions caused 
unprecedented issues with the provision of hospital-based care in Leicester, Leicestershire 
and Rutland, as well as in the UK as a whole. Between May and June in 2020, a digital 
pathway for assisted discharge for patients with COVID-19 was devised by clinicians from 
University Hospitals Leicester NHS Trust, the community specialist respiratory team of 
Leicestershire Partnership Trust and Spirit Digital (Spirit Health Group, Leicester, UK). 
The clinical algorithms used in the COVID-19 digital platform were devised and reviewed 
by two independent respiratory consultants.
It was expected that this change to a virtual model of care would relieve pressure on 
the acute setting, among other potential benefits to patients and healthcare professionals. 
The digital platform was deployed in November 2020, when Leicester, Leicestershire 
and Rutland experienced the second wave of the pandemic. Its onset accompanied the 
capacity issues experienced by acute hospitals during winter, creating severe challenges 
in the delivery of acute care within the region. The increased demand for acute beds 
was exacerbated by the impact of COVID-19 on the workforce, with many clinicians 
either having contracted COVID-19 themselves and self-isolating, or shielding from 
direct patient contact.
At the outset of the pandemic, digital technology was considered potentially useful for 
surveillance, screening, triage, diagnosis, monitoring and contact tracing (Wariri et al, 
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Abstract
Background/Aims In response to high numbers of hospital admissions as a result 
of COVID-19, a virtual ward was implemented to achieve accelerated discharge from 
hospital without compromising patient safety. This study assessed the impact of this 
virtual ward for patients admitted to the acute hospital setting with COVID-19.
Methods A community-based intervention using digital technology and a 
multi-disciplinary team of specialist clinicians to monitor patients at home was 
established. An analysis was carried out within the service investigating the safety, health 
outcomes and resource use of the first 65 patients discharged from hospital into the 
virtual respiratory ward.
Results Red days, where an urgent response was required, decreased from 33.8% of 
patients in their first 3 days at the virtual ward to 10.8% in their final 3 days (P=0.002). 
Four patients were readmitted to hospital, all for clotting disorders. There was one death, 
which was deemed unrelated to COVID-19. Length of stay was also reduced by 40.3% 
(P<0.001) and estimated overall savings were £68 052 (£1047 per patient).
Conclusions The virtual ward appeared to assist with earlier discharges, had a low rate 
of clinically necessary re-admissions, and seemed to reduce costs without compromising 
patient safety. The authors believe that this intervention could be applied across other 
NHS trusts facing similar capacity issues as a result of COVID-19.
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2021). The UK has been at the forefront of the centralised use of digital technology in 
surveillance, diagnostic testing and contact tracing at a national level. The use of digital 
technology to support remote triage and consultations across many clinical disciplines 
has been widespread (Price et al, 2020; Han et al, 2021). The Royal College of General 
Practitioners (2021) has suggested that a mix of remote and face-to-face consultations 
should continue even after the COVID-19 pandemic.
CliniTouch Vie (Spirit Digital, Spirit Health Group, Leicester, UK), the digital app, was 
already in use in the clinical commissioning groups of Leicester, Leicestershire and Rutland 
to support the management of patients with respiratory disease before the pandemic. This 
was not the first virtual ward set up to contend with the COVID-19 pandemic, with similar 
interventions leading to reduced acute bed days (Thornton, 2020). During the first wave of 
the pandemic, it was recognised locally that patients typically bifurcated into two separate 
cohorts: those likely to recover quickly and those expected to deteriorate further, which 
gave a plausible hypothesis to the former cohort being eligible for an early supported 
discharge intervention. After the first wave of the pandemic, information flowed quickly 
on the early use of virtual wards in the UK (Thornton, 2020). In March 2020, virtual wards 
were established. Manchester University Foundation Trust developed the first assisted 
discharge service in the UK, in which patients were managed through regular phone calls. 
Of the first 200 patients, 10% were readmitted (Thornton, 2020). In West Hertfordshire 
NHS Trust, patients were discharged from the emergency department into a virtual ward, 
rather than being admitted. From mid-March to 11 May, 1042 patients with COVID-19 
were admitted to the virtual ward. They estimated that of the first 400 patients, 300 bed 
days were saved in the hospital over 3 weeks (Thornton, 2020). There seemed to be early 
evidence regarding the effectiveness of virtual wards in enhancing hospital capacity, with 
no evidence of patient safety being compromised.
The objective of the digital platform established at University Hospitals Leicester 
NHS Trust was to improve patient flow by enabling the safe discharge of patients at the 
early stages of recovery from COVID-19 infection. It was recognised that this required 
a system-wide approach, with acute hospital services working closely with community 
providers to ensure that patients were monitored following their discharge. A flexible 
model was required to respond to further surges in cases of COVID-19, while also taking 
into account the impact that annual winter pressures would have on local capacity.
This study reports on the deployment and early clinical and economic outcomes of the 
digital pathway at University Hospitals Leicester NHS Trust. The aim of the intervention 
was to create capacity in secondary care, while maintaining patient safety. This is an early 
evaluation to share a description of the service and early outcomes, as healthcare systems 
around the world face ongoing challenges.
Methods
This was an observational evaluation of a novel service, rather than a clinical trial; there 
was no active comparator group, randomisation or blinding. The data reported are of the 
first 65 participants that accessed the intervention. The analysis is primarily narrative 
in nature and describes the early results of the implementation of the virtual ward 
programme. While statistical methods have been employed to determine the validity of 
the initial findings, many endpoints were not pre-specified, no estimate of effects were 
pre-determined and no power calculations were made. The intervention was delivered 
consistently to the patients reported on in this analysis, with no variation in how care was 
organised or delivered. The Standards for Quality Improvement Reporting Excellence 
guidelines were used to structure the paper (Ogrinc et al, 2015). In a systematic review 
of virtual wards, Vindrola-Padros et al (2021) stated that no conclusions could be drawn 
regarding patient safety and the identification of early deterioration because of missing 
data and a lack of standardised reporting. Moreover, in-depth economic analyses were not 
reported in the majority of models analysed in this review, making the financial impact 
of virtual wards difficult to gauge. However, the methods employed in the present study 
aimed to address these issues as much as possible, despite the limitations associated 
with service evaluations.
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The virtual ward was facilitated using CliniTouch Vie, a digital platform that comprises 
both a patient and clinical portal. Clinical data are entered by the patient and uploaded to 
a clinical dashboard, which prioritises patients depending on their responses to clinical 
questions and observations. The platform also allows patients and clinicians to connect via 
message or by embedded video consulting features. The platform can be accessed via any 
smartphone, tablet (Android or IOS) or computer (Windows- or Apple-operating systems).
The specialist respiratory department at University Hospitals Leicester NHS Trust is 
located within Glenfield Hospital. Patients were identified for the service following senior 
medical review at the hospital. The virtual service provided care for patients in Leicester, 
Leicestershire and Rutland, in a partnership between University Hospitals Leicester NHS 
Trust, Leicestershire Partnership Trust and Spirit Digital. The preference was for patients 
to use their own devices to access the platform but, if patients did not have access to a 
suitable device, a smartphone was provided free of charge by Spirit Digital.
The virtual ward service provided remote support and follow up for patients with 
respiratory symptoms admitted to hospital with a clinical diagnosis of COVID-19 and at 
risk of deterioration after discharge. At the time of implementation, because of the lack of 
a validated deterioration risk scoring tool for patients with COVID-19, a clinical decision 
aid was formulated by the respiratory team at University Hospitals Leicester NHS Trust 
to assess patients’ suitability for discharge. To meet the clinical referral criteria for the 
virtual ward, patient needed to be:
 ■ Medically fit for supported discharge, as decided by their designated consultant
 ■ Able to cope at home
 ■ Willing to engage in full active treatment
 ■ In possession of a smartphone, tablet or laptop.
They also needed to have two or more risk factors for increased safety netting from 
the list below:
 ■ <10 days since onset of symptoms
 ■ Respiratory rate of 20–22 breaths per minute
 ■ Oxygen saturations of 92–94%
 ■ Living alone
 ■ Belonging to a clinically extremely vulnerable group.
Once a patient had been identified as clinically suitable and the risk had been estimated, 
the referring team ensured that a decision on escalation had been made and documented 
before discharge on the referral form. A structured discharge process was then initiated 
by staff, in which patients were introduced to the service and confirmed their willingness 
to take part. On the last day before discharge from hospital, patients were registered on 
the virtual platform, provided with a thermometer and pulse oximeter, and taught how to 
use them. On the day of discharge from hospital, patients were assisted in accessing the 
patient portal and completed the first question set, as well as the questions on informed 
consent and data sharing. Staff ensured that patients were confident in using the platform 
and confirmed that patients had the contact details for the respiratory team and the Spirit 
Digital (the providers of the CliniTouch Vie platform) helpline.
Key outcomes
The following were considered the most important endpoints to be evaluated:
 ■ The overall safety of the virtual ward, ie the number and percentage of re-admissions 
and the number and distribution of red days in the virtual ward (a priori)
 ■ The length of hospital stay of those who accessed the virtual ward (a priori) and, to 
establish whether bed days were reduced following the introduction of the virtual 
ward (post hoc)
 ■ The costs associated with the virtual ward (a priori), and the estimated impact on overall 
resource use (post hoc).
Every patient accessing the virtual ward had their daily risk and health status rating 
recorded using the codes red, amber and green (RAG). The number of patients in the 
virtual ward and their RAG status were explored over time. Student’s t-tests (paired and 
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two-tailed) were conducted to compare patients’ scores on their first day, first 3 days, last 
day, last 3 days in the virtual ward. These data were extracted from the CliniTouch database 
and analysed using the Microsoft Excel 365 Data Analysis pack. All re-admissions were 
reported, with the cause of re-admission identified and the case explored by senior clinicians.
Treatment regimes in the first and second wave of the COVID-19 pandemic altered as 
clinical knowledge improved. Patients accessing the virtual ward were compared to the 
entire cohort of patients who did not require either oxygen or intensive monitoring (ie 
broadly comparable patients and treatments) before the introduction of the virtual ward 
in November 2020. 
Information regarding the use of clinical resources on the virtual COVID-19 ward was 
provided by Leicestershire Partnership Trust and the costs of clinician time attached to the 
intervention were sourced from the University of Kent’s Personal Social Services Research 
Unit dataset (Curtis and Burns, 2020). The number of interventions was accessed from the 
CliniTouch Vie database. The cost of 1 bed day in the Glenfield Hospital respiratory wards, 
individual lengths of stay for patients admitted into the virtual ward, and the mean plus 
confidence interval for similar patients (no intensive or high dependency care or oxygen 
administration) admitted and discharged throughout the month of November and immediately 
before the introduction of the virtual ward in Glenfield Hospital were sourced from the 
business team within the University Hospitals Leicester NHS Trust Finance Directorate 
in cooperation with the clinical commissioning groups for Leicester, Leicestershire and 
Rutland. All analyses were based on these datasets.
All patients gave informed consent for their anonymised data to be used for research 
purposes. The evaluation proposal was submitted to the local institutional review board, but 
the need for full ethical approval was waived because the study was a service evaluation. 
Results
A total of 66 patients were admitted to the Leicestershire Partnership Trust virtual ward 
from when it opened in November 2020 up to 31 January 2021. Their ages ranged from 
21.5–87.4 years, with a mean and median age of 56 and 58 years respectively. Data 
regarding patients’ ethnicities were not retained, but 39% of the patients were recorded 
as female. Of the 66 patients, data were available for only 65 individuals, as one patient 
was re-admitted before inputting any data. This admission and the associated costs are 
included in the narrative, but the denominator has been kept as 65 to maintain consistency.
The mean and median length of stay in the virtual ward were 13.2 days and 14 days 
respectively, with only one patient staying for 20 days. Patients were discharged from the 
virtual ward at the discretion of the clinicians and as per hospital protocol. Figure 1 shows 
Figure 1. Day of discharge from the virtual ward for patients admitted between 
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the daily number of patients in the ward, with 91% of patients remaining in the virtual 
ward for 9 days or more.
The number of patients who were re-admitted to the hospital from the virtual ward 
was four (6.2%), and included the patient for whom there was no data. The number of 
patient red alerts on their first day on the virtual ward was 16 (24.6%), with 22 (33.8%) in the 
first 3 days after admission. The number of patients with a red alert on their final day on the 
virtual ward was five (7.7%), with seven (10.8%) in their last 3 days on the virtual ward. This 
represents a relative reduction of 56.3% (P=0.049) in red days from the first day to the last day, 
and 68.2% (P=0.002) from the first three days to the last three days on the virtual ward. The 
absolute number of RAG rating scores over time for the 65 participants is shown in Figure 2.
There was no significant correlation between patient length of stay at the Glenfield 
respiratory wards and length of stay at the virtual ward. The average length of stay in 
the hospital wards before the introduction of the virtual ward in November 2020 was 
5.5 (±1.3) days, while the mean length of stay for those discharged into the virtual ward 
was 3.3 (±0.4) days.
Resource use in the virtual ward
The total number of virtual consultations conducted in response to a patient giving 
a ‘red’ rating in the virtual ward was 109, 30.1% of which were in the first 3 days of 
admission (Table 1). Each red rating led to two video-consultations, with a mean total 
duration of 27.5 minutes. These contacts were conducted by band 7 specialist nurses or 
physiotherapists. Patients with amber ratings in the first week were also contacted, resulting 
in 114 consultations in total. Ten patients with a green rating who had not been contacted 
before were also contacted in the second week as part of the discharge process. The total 
consultation costs for the 65 patients over the 20 days they spent in the virtual ward were 
estimated and are shown in Table 1.
The cost of virtual ward contact per patient was estimated at £93.52. The total cost of 
virtual monitoring via CliniTouch Vie was £2583 (£39.74 per patient) and the total cost 
of monitoring and contacting patients was £8662 (£133.26 per patient). The mean rate of 
readmission to hospital from the virtual ward was 6.2%, with readmission costs totalling 
at £11 704 (£180.06 per patient).
A common adverse outcome of COVID-19 is venous clotting, which has been found in 
20% of patients hospitalised for the virus (The Royal College of General Practitioners, 2021). 
In this cohort, two of the patients who were re-admitted to hospital from the virtual ward on 
day one would likely have had their clotting event while in hospital under usual care, while 
the other two patients had a clotting event on days four and five, at which point, without the 
virtual ward, they likely would have been discharged from hospital and then readmitted.
Figure 2. Red, amber, green (RAG) ratings of 65 patients in the virtual ward over 20 days 
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Early discharge and bed days potentially released
The average length of stay before the introduction of the virtual ward was 5.5 days, decreasing 
to 3.3 days after the virtual ward was implemented, representing a 40% reduction in bed 
days (P<0.001). The mean local estimate of the cost of a bed day in a respiratory ward in 
the Glenfield Hospital in the month of November 2020 was £532. The implications for 
resource savings produced by the virtual ward are summarised in Table 2.
Discussion
These results suggest that the primary goal of increasing acute capacity was achieved 
through the introduction of the virtual COVID-19 ward. Overall, 25% of patients had 
red alerts on their first day in the virtual ward, indicating a reduced health status. If these 
patients had been retained in the hospital for an additional day, which would have been 
likely in usual circumstances, this would have cost a total of £8512, representing 98% of 
the costs of the virtual ward.
For the virtual ward to be cost-neutral, it would need to have reduced bed days by one 
for every four patients referred into it. In actuality, it reduced bed days by 2.2 per patient 
admitted for COVID-19 or related complications. The estimated savings incurred by 
introducing the virtual ward (compared to maintaining the previous discharge protocol) 
were 8.9 times greater than would have been required to make the ward cost-neutral. If the 
costs of all four re-admissions from the virtual ward to the hospital are included, this figure 
decreases, but still represents savings 6.5 times greater than would have been required to 
make the ward cost-neutral.
Table 1. Number of clinician contacts and associated costs by patient 
red, amber, green (RAG) rating over 20 days at the virtual ward
Patient RAG rating n Cost (£)
Red 109 2844
Amber (week one only) 114 2974
Green (week two only) 10 261
Total contacts 233 6079
Source: Curtis and Burns (2020).
Table 2. Summary of resource savings from reductions in average length 
of stay at Glenfield Hospital following the introduction of the virtual ward
Resources Savings
Average length of stay before intervention 5.5 days
Average length of stay post intervention 3.3 days
Bed days
Number of patients seen in virtual ward 65
Bed days saved 144.2 days
Reduction in bed days 40.3%
Costs (£)
Bed days costs averted £76 714
Costs of intervention £8662
Total resources saved £68 052
Resources saved per patient £1047
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However, this intervention was not only about saving resources. On 15 January 2021, 
48% of patients in Glenfield Hospital had been admitted with COVID-19-related disease. 
Creating additional capacity by minimising lengths of stay, while maintaining patient safety, 
was crucial. The direct costs of the virtual ward were relatively low at around £133.26 
per patient, which made it a sustainable intervention, particularly if patients’ average 
length of stay in hospital was reduced. The results align with initial analyses conducted 
in other hospitals regarding the safe reduction of hospital bed days (Thornton, 2020). The 
estimated savings from the virtual ward of over £1000 per patient were substantial, and 
the readmission rate of 6% was relatively low.
It is worth noting that none of the 66 patients withdrew from the virtual ward because of 
system failures or faults. If patient care is to rely more heavily on digitally-supported services 
in the future, systems must be reliable enough to be able to support clinical care. The software 
used for the virtual ward had a 100% success rate in daily sharing of patients’ data with 
clinicians. One patient withdrew at their own discretion on day two and had been rated green 
the previous day. All other patients left the virtual ward with the agreement of clinical staff.
The virtual ward allowed patients to be treated at home, reducing their likelihood of 
contracting a hospital-acquired infection or of infecting staff with COVID-19 which, amid 
a workforce crisis, is paramount. Patients’ symptoms were monitored daily through the 
virtual ward, and the ability to communicate with clinicians via text and video conferencing 
meant that any decline in symptoms could be rapidly identified. Over time, patients’ 
wellbeing broadly improved, as can be seen in the reductions in red and amber days shown 
in Figure 1. This suggests that the virtual ward was successful in reducing length of stay 
without compromising patient safety.
However, as noted by Malas et al (2020), COVID-19 has caused a significant increase in 
adverse blood-clotting outcomes; this was the reason behind the four re-admissions to hospital 
from the virtual ward, resulting in the death of one patient. Two of these four patients had 
their clotting event on the first day after hospital discharge, which potentially delayed access 
to optimised care. All re-admissions were clinically reviewed by senior clinical colleagues 
within University Hospitals Leicester NHS Trust and Leicestershire Partnership Trust, and 
the inference that COVID-19-related disease was the primary attributable factor for the 
readmission could not be ascertained. All patients were on thromboprophylaxis while in the 
hospital, and were mobile on discharge. At the time of the study, the admission criteria for 
the virtual ward excluded patients discharged on oxygen. However, the service has since 
been extended to include these patients, with the aim of weaning them off oxygen as part 
of their recovery from COVID-19. The service intends to report on this cohort of patients 
at a later date.
The COVID-19 pandemic has accelerated a worldwide digital health revolution. The 
unprecedented public health challenge of providing safe care for patients and clinicians, 
while also enabling increased capacity within the healthcare system, would be difficult 
and expensive to sustain within traditional working methods. Digital solutions do not 
replace the key role that clinicians play in the care of their patients, but they can provide 
them with more specific, systematic and prioritised clinical data to enable them to make 
high-quality clinical decisions. A recent paper reported a 3.5-fold increase in re-admissions 
and a 7.7-fold increase in mortality at 140 days for patients discharged from hospital 
Key points
 ■ The virtual COVID-19 ward seemed to reduce bed days by 40% and increase bed 
availability in the hospital.
 ■ The virtual ward accelerated the discharge of patients safely, with a relatively low 
re-admission rate.
 ■ The introduction of the virtual was cost-effective and led to considerable cost savings.
 ■ Access to digital systems can be expanded rapidly to help with future surges in 
infections and has a potential role in expanding into other non-COVID-19-related 
hospital discharges.
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following admission for COVID-19-related disease (Ayoubkhani et al, 2021). The digital 
component of the virtual ward service was easily scaled up, and most UK localities have 
specialist community respiratory teams. Therefore, this model of care could be rapidly 
introduced in other localities or expanded into additional ‘at risk’ cohorts of patients to 
improve outcomes post discharge from hospital.
Limitations
The results were open to bias and confounding, which reflected the environment within which 
the virtual ward was introduced, as a pre-planned emergency response to circumstances. There 
are also inevitable limitations associated with real-world data. The costs of implementing 
the virtual ward intervention were more certain than the potential costs of not implementing 
the virtual ward, making comparison difficult.
Conclusions
The COVID-19 virtual ward seemed to achieve its objective of increasing hospital capacity, 
with a low rate of re-admission. The software used was also reliable in sharing data with 
clinicians. The cost per patient was low and the savings appeared relatively high, making 
the service cost-efficient. The technology is accessible and specialist community respiratory 
teams are commonplace in the UK. Therefore, this service could be reproduced across other 
NHS trusts facing similar capacity pressures as a result of COVID-19, although additional 
and higher-quality data is needed to help inform future practice in this area. 
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